• Explore /
  • Poster
  • / A phase 1b/2 study to evaluate the safety and efficacy of TTI‑101 as monotherapy and in combination in advanced hepatocellular carcinoma.

A phase 1b/2 study to evaluate the safety and efficacy of TTI‑101 as monotherapy and in combination in advanced hepatocellular carcinoma.

Abstract Poster

Authors

Farshid Dayyani

Farshid Dayyani

Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Orange, CA

Farshid Dayyani , Marina Baretti , Sunyoung S. Lee , Aiwu Ruth He , Richard D. Kim , Bruce Shih-Li Lin , Thomas Enzler , Mohammed Najeeb Al Hallak , Susanna Varkey Ulahannan , S. Lindsey Davis , Adam Burgoyne , David Tweardy , James J. Harding , Ahmed Omar Kaseb , Sofia de Achaval , Imran Alibhai , John S. Kauh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05440708

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr TPS577)

DOI

10.1200/JCO.2024.42.3_suppl.TPS577

Abstract #

TPS577

Poster Bd #

P6

Abstract Disclosures

Similar Posters

First Author: Claudia A.M. Fulgenzi

First Author: Takeshi Terashima

First Author: Feng Bi

First Author: Daneng Li